CPSE:BAVABiotechs
Will Bavarian Nordic's (CPSE:BAVA) New 10% Buyback Shift Its Vaccine-Focused Investment Narrative?
Bavarian Nordic A/S has begun a shareholder-authorized buyback program as of January 7, 2026, allowing repurchases of up to 10% of its share capital on Nasdaq Copenhagen at prices within 10% of the prevailing market price, with the mandate running through December 31, 2026.
This move to retire shares adds a new capital allocation element that could influence how investors view Bavarian Nordic’s earnings profile and ownership structure.
We’ll now examine how this newly launched share...